New Year Bumper Sale @ Rs. 1 X
Zogli 15/2 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Diabetes. Zogli 15/2 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Zogli 15/2 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Zogli 15/2 Tablet have been listed ahead. Normally, these side effects of Zogli 15/2 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Zogli 15/2 Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Zogli 15/2 Tablet related warnings talks about Zogli 15/2 Tablet's effects on the liver, heart and kidney.
Zogli 15/2 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zogli 15/2 Tablet in conditions like Heart Disease, Liver Disease, Kidney Disease. Other conditions have been mentioned below in the Zogli 15/2 Tablet contraindications section.
Additionally, Zogli 15/2 Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Zogli 15/2 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Zogli 15/2 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Zogli 15/2 Tablet safe for pregnant women?
Zogli can have harmful effects in pregnant women. If you experience any discomfort after using Zogli, then discontinue the use and take your doctor's advice.
Is the use of Zogli 15/2 Tablet safe during breastfeeding?
Zogli may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Zogli, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Zogli.
What is the effect of Zogli 15/2 Tablet on the Kidneys?
Zogli rarely affects the kidneys.
What is the effect of Zogli 15/2 Tablet on the Liver?
The liver can be affected by Zogli. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Zogli only after medical advice.
What is the effect of Zogli 15/2 Tablet on the Heart?
The heart can be affected by Zogli. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Zogli 15/2 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zogli 15/2 Tablet unless your doctor advises you to do so -
Is this Zogli 15/2 Tablet habit forming or addictive?
Forming a habit of Zogli 15/2 Tablet has not been reported.
Interaction between Food and Zogli 15/2 Tablet
There is no information on the effects of taking Zogli 15/2 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Zogli 15/2 Tablet
Taking Zogli 15/2 Tablet and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033